eFFECTOR Therapeutics Inc. (NASDAQ: EFTR)
$0.19
+0.1090 ( +135.40% ) 1.6M
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).